South Shore Biotherapy

South Shore Biotherapy

Mental Health Office

Print
Claim My Business
Form C
View on Mainvest
Security Type
Revenue Sharing
Categories
Healthcare & Medical
Min Investment
$100
Location
MARSHFIELD, MA
Expected Close Date
April 15, 2022
Target Raise
$75.00K-$107.00K
No. Investors
85
Security Price
$1
Investment Multiple
1.6×
Business’s Revenue Share:
0.8%-1.1%
Securitization
None
Maturity Date
October 1st, 2028
Website
m.facebook.com
Number of Employees
1
Cash
$0
Revenue
$0
Short Term Debt
$0
Cost of Goods
$0
Long Term Debt
$0
Net Income
$0

Company Description

South Shore Biotherapy’s mission is to improve our client’s quality of life through intravenous infusion therapy and provide hope for a brighter future, free of depression and thoughts of suicide.

Use of Proceeds


Facility Lease
$35,000

Medical Equipment
$5,500

Build Out
$10,000

Staff Salary
$14,500

Furnishings
$5,500

Mainvest Compensation
$4,500 Total $75,000
Amount Raised : $103,700
Reveal the Score by Voting
＿
Additional ratings from other users are needed to determine a viable CrowdScore for this deal.
The "CrowdScore" for this deal is determined by user ratings and other factors using our proprietary algorithm.
ⓘ
The overall viability and scalability of the business concept as well as the ability to drive the concept to profitability over time.
Business Idea
ⓘ
The progress made thus far in demonstrating that the business has viability, a customer base or other business traction.
Business Traction
ⓘ
The experience of the management team in running, scaling and/or exiting a business that required similar skills to execute the business plan.
Management Team
ⓘ
The value of the company compared to similar companies raising money from investors.
Valuation

Security Description

Revenue Sharing is a form of lending that involves sharing revenue from the business with investors as return on their investment. It is often a fixed percentage of revenue and you are paid until you earn a total return on your investment.

Research Reports

No reports have been submitted

Become a Reporter
Read Our Research Disclaimer

0 Comments

Post Comment